Please login to the form below

Not currently logged in
Email:
Password:

ABPI's Stephen Whitehead steps down

Leaves the UK pharma trade body after four years as its CEO

Stephen WhiteheadThe Association of the British Pharmaceutical Industry's (ABPI) Stephen Whitehead has left the organisation after serving as CEO for four years.

Speaking on behalf of the board ABPI president John Kearney said: “We want to thank Stephen for the very significant contribution he has made to the transformation and success of the ABPI.

“We wish Stephen the best for the future.”

Whitehead joined the UK trade body in 2011, taking over from Richard Barker, and brought senior experience from Barclays and Allied Domecq.

Earlier in his career, Whitehead spent ten years at GlaxoSmithKline and Eli Lilly at UK, European and international levels.

Once he moved back to pharma he quickly made an impact at the ABPI and in 2012 picked up Healthcare Communiquétor of the Year at the Communiqué Awards in recognition of his positive impact at the Association.

The ABPI said it would now begin searching for a new CEO and in the meantime Alison Clough would continue as acting CEO.

2nd October 2015

From: Regulatory

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Porterhouse Medical Group

The Porterhouse Medical Group provides powerful, insight-driven, scientific and medical communication services to the pharmaceutical industry across the globe, with...

Latest intelligence

Improve clinical trials through patient journey mapping
Could patient journey mapping be your solution to improving clinical study recruitment and retention? While awareness of clinical studies is low across the population, it’s not the only issue. It’s...
InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE....
Alone we can do so little, together we can do so much
Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...

Infographics